Here are four takeaways from the proposed rule:
1. Under the proposed rule, Medicare expects to pay $8.2 billion to approximately 7,800 facilities in 2023 for furnishing renal dialysis services. The proposed 2023 base rate is $264.09, an increase of $6.19 to the current base rate.
2. CMS projects that the updates for 2023 would increase the total payments to all ESRD facilities by 3.1 percent compared with 2022. Hospital-based facilities are expected to see total payments increase by 3.7 percent, and freestanding facilities are projected to see a 3.1 percent bump in total payments.
3. The rule proposes an increase to the wage index floor, a permanent 5 percent cap on decreases to the wage index and a change to the methodology used to calculate the outlier threshold for adult patients.
4. In the proposed rule, CMS is requesting information regarding health equity issues and a potential add-on payment adjustment for certain renal dialysis drugs and biological products.
The proposed rule can be downloaded from the Federal Register.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
